Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Researchers identify the anterior insula as the brain region responsible for biasing decisions toward alcohol over social rewards in addiction.

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.

Aiming to address the connections between addiction and mental health disorders, the Partnership for a Drug-Free New Jersey recently hosted a webinar to discuss the best ways to treat both together.

Ozempic was first approved to treat type 2 diabetes in 2017, but it’s garnered most of its recognition in recent years as a weight-loss drug. Now, as more people are taking it and scientists are ...

According to an app called Sobbefy, answering yes to questions like these meant I could be a love addict. For months, I had ...